Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 320.75M | 237.21M | 275.63M | 326.66M | 223.13M |
Gross Profit | 1.64M | 1.53M | -23.89M | 3.69M | 1.48M |
EBITDA | -10.97M | -10.45M | -33.97M | -5.60M | -7.26M |
Net Income | -11.79M | -11.61M | -36.42M | -8.52M | -8.37M |
Balance Sheet | |||||
Total Assets | 113.68M | 117.09M | 110.32M | 129.28M | 140.36M |
Cash, Cash Equivalents and Short-Term Investments | 35.06M | 47.30M | 44.52M | 42.77M | 31.64M |
Total Debt | 353.00K | 334.00K | 138.00K | 271.00K | 132.00K |
Total Liabilities | 26.54M | 26.18M | 18.06M | 14.38M | 21.66M |
Stockholders Equity | 87.14M | 90.91M | 92.26M | 114.89M | 118.70M |
Cash Flow | |||||
Free Cash Flow | -20.12M | -7.41M | -11.90M | 6.52M | -22.38M |
Operating Cash Flow | -18.98M | -7.07M | -11.90M | 6.95M | -21.38M |
Investing Cash Flow | -975.00K | -280.00K | 7.00K | -378.00K | -702.00K |
Financing Cash Flow | 7.60M | 10.07M | 13.64M | 4.53M | -217.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | HK$3.82B | 7.39 | 9.70% | 6.82% | 2.68% | 8.41% | |
58 Neutral | HK$15.00B | 4.65 | -2.78% | 5.84% | 3.80% | -54.55% | |
48 Neutral | HK$57.14M | ― | -72.83% | ― | 6.83% | -63.75% | |
43 Neutral | HK$180.55M | ― | ― | -37.59% | -244.66% | ||
41 Neutral | HK$49.75M | ― | -11.50% | ― | 30.11% | 12.01% | |
41 Neutral | HK$44.91M | ― | ― | ― | ― | ||
40 Underperform | HK$235.86M | ― | ― | -15.39% | 19.69% |